Cargando…
Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786602/ https://www.ncbi.nlm.nih.gov/pubmed/35097177 http://dx.doi.org/10.1016/j.jdcr.2021.12.002 |
_version_ | 1784639146883547136 |
---|---|
author | Karatas, Elif Nazim, Ali Patel, Parth Vaidya, Toral Drew, George Scott Amin, Sanober A. Keyes, Ashley A. Fonseca, Maira Mir, Adnan Halverstam, Caroline P. |
author_facet | Karatas, Elif Nazim, Ali Patel, Parth Vaidya, Toral Drew, George Scott Amin, Sanober A. Keyes, Ashley A. Fonseca, Maira Mir, Adnan Halverstam, Caroline P. |
author_sort | Karatas, Elif |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8786602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87866022022-01-25 Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series Karatas, Elif Nazim, Ali Patel, Parth Vaidya, Toral Drew, George Scott Amin, Sanober A. Keyes, Ashley A. Fonseca, Maira Mir, Adnan Halverstam, Caroline P. JAAD Case Rep Case Series Elsevier 2022-01-07 /pmc/articles/PMC8786602/ /pubmed/35097177 http://dx.doi.org/10.1016/j.jdcr.2021.12.002 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Series Karatas, Elif Nazim, Ali Patel, Parth Vaidya, Toral Drew, George Scott Amin, Sanober A. Keyes, Ashley A. Fonseca, Maira Mir, Adnan Halverstam, Caroline P. Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series |
title | Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series |
title_full | Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series |
title_fullStr | Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series |
title_full_unstemmed | Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series |
title_short | Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series |
title_sort | erythema multiforme reactions after pfizer/biontech (bnt162b2) and moderna (mrna-1273) covid-19 vaccination: a case series |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786602/ https://www.ncbi.nlm.nih.gov/pubmed/35097177 http://dx.doi.org/10.1016/j.jdcr.2021.12.002 |
work_keys_str_mv | AT karataselif erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT nazimali erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT patelparth erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT vaidyatoral erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT drewgeorgescott erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT aminsanobera erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT keyesashleya erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT fonsecamaira erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT miradnan erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries AT halverstamcarolinep erythemamultiformereactionsafterpfizerbiontechbnt162b2andmodernamrna1273covid19vaccinationacaseseries |